Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Prognostic impact of clinician-based interpretation of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Increased risk of anemia, neutropenia and thrombocytopenia in people with HIV and well-controlled viral replication

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Blodsygdomme

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiFormidling

  • Karen J Mylam
  • Tarec Christoffer El-Galaly
  • Martin Hutchings
  • Peter Brown
  • Bodil Himmelstrup
  • Oke Gerke
  • Dorte Gillstrøm
  • Ida Blok Sillesen
  • Lars Munksgaard
  • Bjarne B Pedersen
  • Ilse Christiansen
  • Paw Jensen
  • Anne Louise Nielsen
  • Lars M Pedersen
Vis graf over relationer
The aim of this study was to evaluate the prognostic value of clinician interpretation of positron emission tomography/computed tomography (PET/CT) reports at mid-therapy, interim PET (I-PET) and after the end of first-line therapy (E-PET) in patients with diffuse large B-cell lymphoma (DLBCL). Four hundred and thirty patients were enrolled in this study comprising a total of 617 PET reports. Each report was evaluated by three expert hematologists randomly selected from a panel of nine. Reports were labeled positive or negative if all three interpreters agreed. All others were considered indeterminate. Indeterminate reports accounted for 59% of I-PET and 49% of E-PET reports. Two-year overall survival (OS) for patients with a positive, indeterminate and negative I-PET was 58%, 87% and 89% (p
OriginalsprogEngelsk
TidsskriftLeukemia and Lymphoma
Vol/bind55
Udgave nummer7
Sider (fra-til)1563-69
ISSN1042-8194
DOI
StatusUdgivet - 2014

ID: 42573481